X4 PharmaceuticalsXFOR
13F holders, Q2 2025 (June 30)2holders −90
0new positions
52sold out
$1.90avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding X4 Pharmaceuticals Inc. (XFOR) in their 13F filings, down 90 from Q1 2025. 0 opened new positions and 52 sold out. The largest holders were NEA Management Company, LLC ($949K) and Acorn Capital Advisors, LLC ($292K).
- Company
- X4 Pharmaceuticals Inc.
- CUSIP
- 98420X103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 52 | $3.5M |
All 13F filers, Q1 2025 → Q2 2025: 35,533,329 shares sold, net −35,533,329 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| NEA Management Company, LLC | 0.07% | Reduce -96.7% | 499,559 | $949K |
| Acorn Capital Advisors, LLC | 0.19% | Reduce -97.9% | 153,730 | $292K |
"% of holder's portfolio" is XFOR's weight in each manager's 13F, not the share of X4 Pharmaceuticals Inc. the manager owns.